Blogs & News

Diltiazem Fails to Improve Vasomotor Dysfunction, Angina in ANOCA: EDIT-CMD

In a randomized trial of patients with angina and no obstructive Coronary artery disease(ANOCA), 6 weeks of treatment with diltiazem did not improve coronary vasomotor dysfunction — apart from epicardial spasm — or angina symptoms and quality of life. The trial investigated whether this therapy would improve these outcomes in patients with two endotypes of […]

Conference News

Hypertension Control During Pregnancy Validated in Large Trial

Pregnant women with even mild hypertension should receive blood pressure–lowering medications to reduce the likelihood of adverse outcomes for the mother and the child, according to a large, open-label, randomized trial. “Treating to the blood pressure goal in this study reduced the risk of adverse events associated with pregnancy but did not impair fetal growth,” […]

Conference News

Long COVID & Diabetes : Increased Risk and Disease Burden

In the post-acute phase, we report increased risks and 12-month burdens of incident diabetes and antihyperglycaemic use in people with COVID-19 compared with a contemporary control group of people who were enrolled during the same period and had not contracted SARS-CoV-2, and a historical control group from a pre-pandemic era. Post-acute COVID-19 care should involve […]

COVID-19 Study Updates

Low-Sodium Diet Did Not Cut Clinical Events in Heart Failure Trial

A low-sodium diet was not associated with a reduction in future clinical events in a new study in ambulatory patients with Heart Failure. But there was a moderate benefit on quality of life and New York Heart Association (NYHA) functional class. The results of the SODIUM-HF trial were presented today at the American college of […]

Conference News

Rise in Oral Cancers in Young Nonsmokers Tied to Immunodeficiency

Younger, nonsmoking oral cancer patients have a higher risk of death than that of young smokers, and the outcomes may be related to immune deficiencies. The finding comes from a database of oral cavity squamous cell carcinoma (OSCC) patients treated between 1985 and 2015. Recent studies have shown an association between high neutrophil to lymphocyte […]

Health News

Complete Shutdown of Medical Services in Rajasthan

Jaipur : The Doctors across the State of Rajasthan has now called for a Complete Shutdown of services Which includes Routine OPD,IPD, Diagnostic and Emergency Services on Saturday ,22nd April 2022 Demanding Justice for Dr. Archana Sharma . The doctors have demanded that an abetement to suicide case is to be filed against Six Culprits […]

Doctors News

Empagliflozin improves Cognitive impairment in Frail Diabetics with HFpEF

Empagliflozin improves Cognitive impairment in Frail Diabetics with HFpEF Italy: Empagliflozin a SGLT2 inhibitor improves the cognitive and Physical impairment in frail older adults Heart failure with Preserved Ejection Fraction and Type 2 Diabetes a recent study has found. It is to be noted that this study was published in Journal Diabetes care on March […]

Diabetes and Endocrinology

Chest CT Lesion Size in Acute COVID-19 Can Predict Late Myocardial Injury

Chest CT Lesion Size in Acute COVID-19 Can Predict Late Myocardial Injury NOTE :The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. KEY POINTS: 1:Left ventricular (LV) and right ventricular (RV) global longitudinal strain (GLS) were reduced in patients with severe pulmonary lesions (at […]

COVID-19 Study Updates

FDA Approved New Med for Lennox – Gastaut Syndrome

Gastaut Syndrome – FDA Approved New Med for Lennox The US Food and Drug Administration (FDA) has approved fenfluramine (Fintepla) oral solution, a Schedule IV controlled substance, for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in children aged 2 years and older, the company has announced. Fenfluramine is already approved in the US […]

New Drug Approvals
Sorry this site disable right click
Sorry this site disable selection
Sorry this site is not allow cut.
Sorry this site is not allow copy.
Sorry this site is not allow paste.
Sorry this site is not allow to inspect element.
Sorry this site is not allow to view source.